CN115433769A - 血浆dna的单分子测序 - Google Patents

血浆dna的单分子测序 Download PDF

Info

Publication number
CN115433769A
CN115433769A CN202211147693.8A CN202211147693A CN115433769A CN 115433769 A CN115433769 A CN 115433769A CN 202211147693 A CN202211147693 A CN 202211147693A CN 115433769 A CN115433769 A CN 115433769A
Authority
CN
China
Prior art keywords
dna
dna fragments
sequencing
nanopore
concatemer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211147693.8A
Other languages
English (en)
Chinese (zh)
Inventor
卢煜明
赵慧君
郑淑恒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinese University of Hong Kong
Original Assignee
Chinese University of Hong Kong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinese University of Hong Kong filed Critical Chinese University of Hong Kong
Publication of CN115433769A publication Critical patent/CN115433769A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
    • G01N33/48721—Investigating individual macromolecules, e.g. by translocation through nanopores
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/50—Other enzymatic activities
    • C12Q2521/501—Ligase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/151—Modifications characterised by repeat or repeated sequences, e.g. VNTR, microsatellite, concatemer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/191—Modifications characterised by incorporating an adaptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/197—Modifications characterised by incorporating a spacer/coupling moiety
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00—Reactions demanding special reaction conditions
    • C12Q2527/146—Concentration of target or template
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/60—Detection means characterised by use of a special device
    • C12Q2565/631—Detection means characterised by use of a special device being a biochannel or pore
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nanotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
CN202211147693.8A 2015-08-12 2016-08-12 血浆dna的单分子测序 Pending CN115433769A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562204396P 2015-08-12 2015-08-12
US62/204,396 2015-08-12
PCT/CN2016/094802 WO2017025059A1 (en) 2015-08-12 2016-08-12 Single-molecule sequencing of plasma dna
CN201680046621.0A CN107849607B (zh) 2015-08-12 2016-08-12 血浆dna的单分子测序

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201680046621.0A Division CN107849607B (zh) 2015-08-12 2016-08-12 血浆dna的单分子测序

Publications (1)

Publication Number Publication Date
CN115433769A true CN115433769A (zh) 2022-12-06

Family

ID=57983895

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202211147693.8A Pending CN115433769A (zh) 2015-08-12 2016-08-12 血浆dna的单分子测序
CN201680046621.0A Active CN107849607B (zh) 2015-08-12 2016-08-12 血浆dna的单分子测序

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201680046621.0A Active CN107849607B (zh) 2015-08-12 2016-08-12 血浆dna的单分子测序

Country Status (12)

Country Link
US (2) US11319586B2 (cg-RX-API-DMAC7.html)
EP (1) EP3334843A4 (cg-RX-API-DMAC7.html)
JP (3) JP6867045B2 (cg-RX-API-DMAC7.html)
CN (2) CN115433769A (cg-RX-API-DMAC7.html)
AU (3) AU2016305103C1 (cg-RX-API-DMAC7.html)
CA (1) CA2995422A1 (cg-RX-API-DMAC7.html)
HK (1) HK1248286A1 (cg-RX-API-DMAC7.html)
IL (3) IL285795B (cg-RX-API-DMAC7.html)
MY (1) MY188348A (cg-RX-API-DMAC7.html)
SA (1) SA518390907B1 (cg-RX-API-DMAC7.html)
TW (2) TWI728994B (cg-RX-API-DMAC7.html)
WO (1) WO2017025059A1 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7084470B2 (ja) 2017-08-23 2022-06-14 エフ.ホフマン-ラ ロシュ アーゲー 酵素のスクリーニング法
KR20200060410A (ko) * 2017-09-07 2020-05-29 쿠퍼제노믹스, 인크. 비침습적 착상전 유전자 진단을 위한 방법과 시스템 (systems and methods for non-invasive preimplantation genetic diagnosis)
WO2019084158A1 (en) 2017-10-26 2019-05-02 Ultima Genomics, Inc. METHODS AND SYSTEMS FOR SEQUENCE CALL
EP3731959B1 (en) 2017-12-29 2025-10-08 Clear Labs, Inc. Automated priming and library loading device
WO2019204720A1 (en) * 2018-04-20 2019-10-24 The Regents Of The University Of California Nucleic acid sequencing methods and computer-readable media for practicing same
WO2020185790A1 (en) 2019-03-10 2020-09-17 Ultima Genomics, Inc. Methods and systems for sequence calling
CN114303202A (zh) 2019-06-21 2022-04-08 酷博尔外科器械有限公司 用于确定胚胎中遗传模式的系统和方法
WO2021108532A2 (en) * 2019-11-25 2021-06-03 William Marsh Rice University Linear dna assembly for nanopore sequencing
US20230249178A1 (en) 2020-07-08 2023-08-10 Roche Sequencing Solutions, Inc. Split-pool synthesis apparatus and methods of performing split-pool synthesis
WO2022081741A1 (en) 2020-10-15 2022-04-21 Roche Sequencing Solutions, Inc. Electrophoretic devices and methods for next-generation sequencing library preparation
CN114507708A (zh) * 2020-11-16 2022-05-17 唐纳德·李 一种制备长分子测序dna的方法
WO2022194764A1 (en) 2021-03-15 2022-09-22 F. Hoffmann-La Roche Ag Targeted next-generation sequencing via anchored primer extension
WO2022200485A1 (en) 2021-03-26 2022-09-29 F. Hoffmann-La Roche Ag Hybridization buffer formulations
EP4314337A1 (en) 2021-04-01 2024-02-07 F. Hoffmann-La Roche AG Immune cell counting of sars-cov-2 patients based on immune repertoire sequencing
IL307398A (en) * 2021-04-12 2023-12-01 Univ Hong Kong Chinese Base change analysis using electrical signals
WO2023023561A1 (en) * 2021-08-17 2023-02-23 Quantapore, Inc. Multiplex binding assays with optical nanopore readout
US20250243536A1 (en) * 2021-10-18 2025-07-31 Belgian Volition Srl Use of nanopore sequencing for determining the origin of circulating dna
EP4547839A1 (en) 2022-06-30 2025-05-07 Kapa Biosystems, Inc. Controlling for tagmentation sequencing library insert size using archaeal histone-like proteins
CN114898802B (zh) * 2022-07-14 2022-09-30 臻和(北京)生物科技有限公司 基于血浆游离dna甲基化测序数据的末端序列频率分布特征确定方法、评价方法及装置
WO2024046992A1 (en) 2022-09-02 2024-03-07 F. Hoffmann-La Roche Ag Improvements to next-generation target enrichment performance
JP2026519344A (ja) 2023-04-13 2026-06-16 ベンタナ メディカル システムズ, インコーポレイテッド 固定固形腫瘍に対する増殖アッセイ
JP2026524816A (ja) 2023-06-14 2026-07-24 エフ. ホフマン-ラ ロシュ アーゲー 加速された5-ホルミルシトシンのマーキングおよび核酸メチル化シーケンシングにおける使用
WO2025193604A1 (en) 2024-03-11 2025-09-18 Ventana Medical Systems, Inc. Non-enzymatic dissociation of ffpe tissue and generation of single cells with intact cell surface markers
WO2025210056A1 (en) 2024-04-03 2025-10-09 Roche Sequencing Solutions, Inc. In vitro amplification of dna methylation patterns
WO2025247632A1 (en) 2024-05-27 2025-12-04 European Molecular Biology Laboratory Preparation of cell-free fragmented nucleic acids for genetic analysis sequencing
WO2026082489A1 (en) 2024-10-18 2026-04-23 F. Hoffmann-La Roche Ag Universal pcr to boost molecule recovery in cell free dna library preparation and target enrichment workflows
WO2026087220A1 (en) 2024-10-22 2026-04-30 F. Hoffmann-La Roche Ag Preparation of dna libraries for next generation sequencing using y-adapters modified with phosphorothioate bonds
WO2026093331A1 (en) 2024-10-28 2026-05-07 F. Hoffmann-La Roche Ag Hairpin adapter constructs and primers to generate next-generation sequencing library molecules
WO2026099278A1 (en) 2024-11-08 2026-05-15 F. Hoffmann-La Roche Ag Normalizing and pooling of pcr-free sequencing libraries
WO2026151663A1 (en) 2025-01-07 2026-07-16 Kapa Biosystems, Inc. Selective rna tagging methods of total nucleic samples for sequencing applications

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012060595A2 (en) * 2010-11-01 2012-05-10 Lg Electronics Inc. Structure with nanopore and apparatus for determining sequences of nucleic acids including the same
CN103003447A (zh) * 2011-07-26 2013-03-27 维里纳塔健康公司 用于确定样品中存在或不存在不同非整倍性的方法
CN103827320A (zh) * 2011-07-25 2014-05-28 牛津纳米孔技术有限公司 使用跨膜孔进行双链多核苷酸测序的发夹环方法
CN107002130A (zh) * 2014-11-11 2017-08-01 深圳华大基因研究院 多程测序

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020197618A1 (en) 2001-01-20 2002-12-26 Sampson Jeffrey R. Synthesis and amplification of unstructured nucleic acids for rapid sequencing
GB0504774D0 (en) * 2005-03-08 2005-04-13 Lingvitae As Method
JP2008161056A (ja) 2005-04-08 2008-07-17 Hiroaki Mita Dna配列解析装置、dna配列解析方法およびプログラム
US12054776B2 (en) 2007-07-23 2024-08-06 The Chinese University Of Hong Kong Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing
AU2009325069B2 (en) 2008-12-11 2015-03-19 Pacific Biosciences Of California, Inc. Classification of nucleic acid templates
DE102008061772A1 (de) * 2008-12-11 2010-06-17 Febit Holding Gmbh Verfahren zur Untersuchung von Nukleinsäure-Populationen
LT3241914T (lt) 2009-11-05 2019-04-25 The Chinese University Of Hong Kong Vaisiaus genomo analizė iš motinos biologinio mėginio
CA2780016C (en) 2009-11-06 2017-09-19 The Chinese University Of Hong Kong Size-based genomic analysis
US9121823B2 (en) * 2010-02-19 2015-09-01 The Trustees Of The University Of Pennsylvania High-resolution analysis devices and related methods
KR102040307B1 (ko) 2010-11-30 2019-11-27 더 차이니즈 유니버시티 오브 홍콩 암과 연관된 유전적 또는 분자적 이상들의 검출
US20130040827A1 (en) * 2011-08-14 2013-02-14 Stephen C. Macevicz Method and compositions for detecting and sequencing nucleic acids
CA2861457A1 (en) 2012-01-20 2013-07-25 Genia Technologies, Inc. Nanopore based molecular detection and sequencing
GB2559073A (en) * 2012-06-08 2018-07-25 Pacific Biosciences California Inc Modified base detection with nanopore sequencing
JP2015525077A (ja) * 2012-06-15 2015-09-03 ジェニア・テクノロジーズ・インコーポレイテッド チップの構成および高精度な核酸配列決定
US11261494B2 (en) * 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
GB201215449D0 (en) 2012-08-30 2012-10-17 Zoragen Biotechnologies Llp Method of detecting chromosonal abnormalities
HUE053822T2 (hu) 2012-09-20 2021-07-28 Univ Hong Kong Chinese Nem invazív módszer daganat metilom meghatározása plazmából
IL274464B2 (en) * 2013-12-11 2023-08-01 Accuragen Holdings Ltd Preparations and methods for the detection of rare sequence variants
AU2016406443A1 (en) 2016-05-10 2018-11-15 Nec Corporation Demand and supply adjustment system, control apparatus, control method, and program

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012060595A2 (en) * 2010-11-01 2012-05-10 Lg Electronics Inc. Structure with nanopore and apparatus for determining sequences of nucleic acids including the same
CN103827320A (zh) * 2011-07-25 2014-05-28 牛津纳米孔技术有限公司 使用跨膜孔进行双链多核苷酸测序的发夹环方法
CN103003447A (zh) * 2011-07-26 2013-03-27 维里纳塔健康公司 用于确定样品中存在或不存在不同非整倍性的方法
CN107002130A (zh) * 2014-11-11 2017-08-01 深圳华大基因研究院 多程测序

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NANNAN LIU等: "Two-way nanopore sensing of sequence-specific oligonucleotides and small-molecule targets in complex matrices using integrated DNA supersandwich structures", 《ANGEW CHEM INT ED ENGL》, vol. 52, no. 7, 10 January 2013 (2013-01-10), pages 2007 - 2011 *

Also Published As

Publication number Publication date
CA2995422A1 (en) 2017-02-16
EP3334843A1 (en) 2018-06-20
AU2020202153A1 (en) 2020-04-16
JP7810455B2 (ja) 2026-02-03
CN107849607B (zh) 2022-10-11
AU2020202153B2 (en) 2023-02-02
JP7506408B2 (ja) 2024-06-26
TWI793586B (zh) 2023-02-21
WO2017025059A1 (en) 2017-02-16
IL285795B (en) 2022-07-01
IL257074A (en) 2018-03-29
IL294192B2 (en) 2023-08-01
AU2016305103B2 (en) 2020-01-02
US20170044606A1 (en) 2017-02-16
JP6867045B2 (ja) 2021-04-28
AU2023202572A1 (en) 2023-05-18
SA518390907B1 (ar) 2021-09-08
MY188348A (en) 2021-12-02
EP3334843A4 (en) 2019-01-02
IL294192A (en) 2022-08-01
JP2018531583A (ja) 2018-11-01
TW201718874A (zh) 2017-06-01
IL294192B1 (en) 2023-04-01
CN107849607A (zh) 2018-03-27
TWI728994B (zh) 2021-06-01
IL257074B (en) 2021-09-30
US11319586B2 (en) 2022-05-03
HK1245850A1 (zh) 2018-08-31
US20220205038A1 (en) 2022-06-30
JP2021118691A (ja) 2021-08-12
HK1248286A1 (zh) 2018-10-12
AU2023202572B2 (en) 2025-04-10
AU2016305103C1 (en) 2020-06-04
IL285795A (en) 2021-09-30
AU2016305103A1 (en) 2018-03-22
TW202130815A (zh) 2021-08-16
JP2024113130A (ja) 2024-08-21

Similar Documents

Publication Publication Date Title
JP7810455B2 (ja) 血漿dnaの単分子配列決定
TWI867325B (zh) 利用血漿中dna的尺寸及數量畸變以偵測癌症
KR101974492B1 (ko) 샘플 중 상이한 이수성의 존재 또는 부재를 결정하는 방법
EP3704268B1 (en) Normalizing tumor mutation burden
EP3800272B1 (en) Size-based analysis of fetal dna fraction in maternal plasma
TWI727938B (zh) 血漿粒線體dna分析之應用
CN110023509A (zh) 基因型分型测定中的非独特条形码
US12416047B2 (en) Noninvasive prenatal diagnostic methods
HK40083172A (en) Single-molecule sequencing of plasma dna
HK1245850B (en) Single-molecule sequencing of plasma dna
HK1246361B (en) Size-based analysis of fetal dna fraction in maternal plasma
HK1245842B (en) Size-based analysis of fetal dna fraction in maternal plasma
HK1240279B (en) Using size and number aberrations in plasma dna for detecting cancer

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40083172

Country of ref document: HK

RJ01 Rejection of invention patent application after publication

Application publication date: 20221206